Search CLB
Core Laboratories Inc. /DE/
NYSE · CIK 1958086
Last close9.92
Daily change+0.16 (1.64%)
10 Years gain-84.82%
Dividends TTM0.04 (+0.00%)
Dividend yield0.41%
Fundamental Analysis
CLB · STANDARD
SIC 1389 · Oil & Gas Field Services, NEC · Fiscal year end 1231
Fundamental
35.6Momentum
49.1Acceleration
49.1Confidence
84.0Annual Revenue5
Quarterly Revenue15
Annual CFO5
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth3.2 / 25
Quality15.6 / 25
Capital Efficiency7.9 / 20
Balance Sheet7.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Net debt reductionNet debt declined versus the comparison period.
Key Metrics
Revenue Growth TTM-1.37%OK
Revenue CAGR 3Y2.44%OK
Gross Margin19.38%OK
Operating Margin9.25%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC10.74%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y0.22%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $526.52M | $108.93M | $56.47M | $37.03M | $25.82M | 20.69% | 10.72% | 4.9% | 10.51% | 47.03M |
| 2025 FY Dec 31, 2024 | $523.85M | $103.33M | $58.56M | $56.39M | $44.50M | 19.72% | 11.18% | 8.49% | 11.15% | 47.69M |
| 2025 FY Dec 31, 2023 | $509.79M | $109.83M | $54.64M | $24.79M | $14.21M | 21.54% | 10.72% | 2.79% | 13.65% | 47.52M |
| 2024 FY Dec 31, 2022 | $489.74M | $96.08M | $41.52M | $24.96M | $14.74M | 19.62% | 8.48% | 3.01% | 11.19% | 46.81M |
| 2023 FY Dec 31, 2021 | $470.25M | n/a | $45.26M | $36.58M | $23.04M | n/a | 9.63% | 4.9% | n/a | 46.69M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $511.09M | sum latest 4 fiscal quarters Revenue | OK | 0001193125-26-326345, 0001193125-25-248736 |
| Revenue Growth TTM | -1.37% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001193125-26-326345, 0001193125-25-248736 |
| Revenue CAGR 3Y | 2.44% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-118177 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001193125-26-118177 |
| Gross Profit CAGR 3Y | 4.27% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-118177 |
| Operating Income Growth | -3.16% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001193125-26-326345, 0001193125-25-248736 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 19.38% | Gross Profit / Revenue | OK | 0001193125-26-326345, 0001193125-25-248736 |
| Operating Margin | 9.25% | Operating Income / Revenue | OK | 0001193125-26-326345, 0001193125-25-248736 |
| ROIC | 10.74% | NOPAT / Average Invested Capital | OK | 0001193125-26-326345, 0001193125-25-248736 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001193125-26-326345 |
| Interest Coverage | 4.26x | Operating Income / abs(Interest Expense) | OK | derived |
| Current Ratio | 2.12x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.2x | (Cash + Short-term Investments) / Total Debt | OK | 0001193125-26-326345 |